Dr. Huang is an investigator for Interventional Cardiology and Adult Congenital Heart Disease clinical trials through the Sutter Heart & Vascular Institute at Sutter Medical Center Sacramento.
Sutter Health Research Enterprise
2800 L Street, 6th Floor
Sacramento, CA, 95816
(916) 887-4040
SHVICR@sutterhealth.org
Primary Research Interests
Related Clinical Trials
Clasp IID/IIF- (CPMC, ABSMC, MPMC, SIMR)
Edwards PASCAL CLASP IID/IIF Pivotal Clinical Trial (CLASP IID/IIF)
Investigators: Pei-Hsiu Huang M.D., Dr. Christian Spies MD
Status: Active, Recruiting
MedStar Low Risk TAVR
Feasibility of Transcatheter Aortic Valve Replacement in Low-Risk Patients With Symptomatic, Severe Aortic Stenosis
Investigators: Pei-Hsiu Huang M.D., David K. Roberts, III, M.D. FACC
Status: Active, Not Recruiting
PARTNER 3 Low Risk TAVR
The PARTNER 3 - Trial - The Safety and Effectiveness of the SAPIEN 3 Transcatheter Heart Valve in Low Risk Patients With Aortic Stenosis (P3)
Investigators: Pei-Hsiu Huang M.D., Michael T. Ingram, Sr. M.D., Robert Kincade M.D., FACS, David K. Roberts, III, M.D. FACC
Status: Active, Not Recruiting
The PARTNER 3 - AVIV Trial (P3-AVIV)
P3-AVIV is a Prospective, Multicenter Clinical Trial That Will Establish the Safety and Efficacy of SAPIEN 3 THV in Patients With a Failing Aortic Valve
Investigators: Pei-Hsiu Huang M.D., David K. Roberts, III, M.D. FACC
Status: Active, Recruiting
Triluminate
TRILUMINATE Pivotal Trial
Investigators: David Daniels MD, Pei-Hsiu Huang M.D., Brett Sheridan MD, FACS, Dr. Christian Spies MD, Jonathan M Wong M.D.
Status: Active, Not Recruiting